Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 1
2001 1
2003 1
2004 1
2005 2
2006 1
2007 5
2008 9
2009 8
2010 12
2011 17
2012 20
2013 27
2014 30
2015 39
2016 36
2017 25
2018 20
2019 25
2020 26
2021 43
2022 32
Text availability
Article attribute
Article type
Publication date

Search Results

355 results
Results by year
Filters applied: . Clear all
Page 1
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial.
Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U. Murthy V, et al. Among authors: rangarajan v. J Clin Oncol. 2021 Apr 10;39(11):1234-1242. doi: 10.1200/JCO.20.03282. Epub 2021 Jan 26. J Clin Oncol. 2021. PMID: 33497252 Clinical Trial.
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, Sharma M, Sachdev M, Grover AK, Surve A, Budharapu A, Ramadhin AK, Tripathi AK, Gupta A, Bhargava A, Sahu A, Khairnar A, Kochar A, Madhavani A, Shrivastava AK, Desai AK, Paul A, Ayyar A, Bhatnagar A, Singhal A, Nikose AS, Bhargava A, Tenagi AL, Kamble A, Nariani A, Patel B, Kashyap B, Dhawan B, Vohra B, Mandke C, Thrishulamurthy C, Sambare C, Sarkar D, Mankad DS, Maheshwari D, Lalwani D, Kanani D, Patel D, Manjandavida FP, Godhani F, Agarwal GA, Ravulaparthi G, Shilpa GV, Deshpande G, Thakkar H, Shah H, Ojha HR, Jani H, Gontia J, Mishrikotkar JP, Likhari K, Prajapati K, Porwal K, Koka K, Dharawat KS, Ramamurthy LB, Bhattacharyya M, Saini M, Christy MC, Das M, Hada M, Panchal M, Pandharpurkar M, Ali MO, Porwal M, Gangashetappa N, Mehrotra N, Bijlani N, Gajendragadkar N, Nagarkar NM, Modi P, Rewri P, Sao P, Patil PS, Giri P, Kapadia P, Yadav P, Bhagat P, Parekh R, Dyaberi R, Chauhan RS, Kaur R, Duvesh RK, Murthy R, Dandu RV, Kathiara R, Beri R, Pandit R, Rani RH, Gupta R, Pherwani R, Sapkal R, Mehta R, Tadepalli S, Fatima S, Karmarkar S, Patil SS, Shah S, Shah S, Shah S, Dubey S, Gandhi S, Kanakpur S, Mohan S, Bhomaj S, Kerkar S, Jariwala S, Sahu S, Tara S, Maru SK, Jhavar S, Sharma S, Gupta S, Kumari S, Das S, Menon S, Burkule S, Nisar SP, Kaliaperumal S, Rao S, Pakrasi S, Rathod S, Biradar SG, Kumar S, Dutt S, Bansal S, Ravani SA, Lohiya S, Ali Rizvi SW, Gokhale T, Lahane TP, Vukkadala T, Grover T, Bhesaniya T, Chawla U, Singh U, Une VL, Nandedkar V, Subramaniam V, Eswaran V, Chaudhry VN, Rangarajan V, Dehane V, Sahasrabudhe VM, Sowjanya Y, Tupkary Y, Phadke Y; members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group. Sen M, et al. Among authors: rangarajan v. Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21. Indian J Ophthalmol. 2021. PMID: 34156034 Free PMC article.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K. Patil VM, et al. Among authors: rangarajan v. Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31. Cancer. 2019. PMID: 31150120 Free article. Clinical Trial.
PET/CT Normal Variants and Pitfalls in Pediatric Disorders.
Agrawal A, Shah S, Gnanasegaran G, Rajkotia S, Purandare N, Puranik A, Rangarajan V. Agrawal A, et al. Among authors: rangarajan v. Semin Nucl Med. 2021 Nov;51(6):572-583. doi: 10.1053/j.semnuclmed.2021.06.007. Epub 2021 Jul 7. Semin Nucl Med. 2021. PMID: 34243902 Review.
Carcinosarcoma Gallbladder With Osteosarcomatous Differentiation.
Suthar RR, Agrawal A, Bal M, Purandare N, Shah S, Puranik A, Rangarajan V. Suthar RR, et al. Among authors: rangarajan v. Clin Nucl Med. 2021 Oct 1;46(10):e488-e489. doi: 10.1097/RLU.0000000000003654. Clin Nucl Med. 2021. PMID: 33867454
Resistant hypertension.
Romano S, Chacko SJ, Rangarajan V, Chung J, Farzaneh-Far A. Romano S, et al. Among authors: rangarajan v. Am J Med. 2015 Oct;128(10):e23-5. doi: 10.1016/j.amjmed.2015.05.008. Am J Med. 2015. PMID: 26021812 No abstract available.
Gallbladder malakoplakia masquerading as malignant primary on 18F-FDG PET/CT.
Bedmutha AS, Agrawal A, Suthar RR, Agrawal T, Purandare N, Shah S, Puranik A, Kumar R, Rangarajan V. Bedmutha AS, et al. Among authors: rangarajan v. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):323-324. doi: 10.1007/s00259-020-04829-4. Epub 2020 May 13. Eur J Nucl Med Mol Imaging. 2021. PMID: 32405736 No abstract available.
Potential therapeutic applications of biosurfactants.
Gudiña EJ, Rangarajan V, Sen R, Rodrigues LR. Gudiña EJ, et al. Among authors: rangarajan v. Trends Pharmacol Sci. 2013 Dec;34(12):667-75. doi: 10.1016/j.tips.2013.10.002. Epub 2013 Oct 29. Trends Pharmacol Sci. 2013. PMID: 24182625 Review.
355 results